| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |